Trial Profile
A Study to Evaluate the Prognostic Value of Various MRI Progression Patterns for Survival in Patients With Recurrent Malignant Gliomas Treated With Bevacizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 10 May 2016 New trial record